Sort   by:  
 Page size 
UnknownMetformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits.
Not available
S-EPMC7567856 | biostudies-literature
ProteomicsProtein profile at different cellular fractions of Mycobacterium tuberculosis strains after exposure to Isoniazid
Out of the 10 million of tuberculosis (TB) cases estimated in the world, around 14% are isoniazid (INH) resistant among new cases and 29% among previously treated cases in the last decade. INH is one of the oldest but also one of the more potent drugs to eliminate Mycobacterium tuberculosis (Mtb), t...
ORGANISM(S): Mycobacterium tuberculosis H37Rv 
2019-06-17 | PXD007588 | Pride
Cellular fractions Tuberculosis Isoniazid Shotgun proteomics Lc-ms/ms 
UnknownDiscovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
Not available
S-EPMC5038265 | biostudies-literature
UnknownO-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection.
Not available
S-EPMC3795050 | biostudies-literature
UnknownHeterogeneity in immune cell composition is associated with Mycobacterium tuberculosis replication at the granuloma level.
Not available
S-EPMC11381408 | biostudies-literature
TranscriptomicsTime course RNA-seq of Mycobacterium tuberculosis exposed to nitric oxide.
Mycobacterium tuberculosis is an intracellular human pathogen with the ability to resist and adapt to many adverse conditions it encounters upon infection. Among these, overcoming the production of nitric oxide by macrophages could be key for M. tuberculosis success. We have challenged M. tuberculo...
ORGANISM(S): Mycobacterium tuberculosis H37Rv 
2017-08-29 | E-MTAB-5557 | biostudies-arrayexpress
UnknownAmyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.
Not available
S-EPMC3997518 | biostudies-literature
UnknownSystem-wide investments generate health and enhance HIV, TB and malaria control in Malawi
Not available
S-EPMC13642251 | biostudies-literature
UnknownTherapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations.
Not available
S-EPMC9459154 | biostudies-literature
UnknownBCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis.
Not available
S-EPMC7755135 | biostudies-literature
Sort   by:  
 Page size